Financial Summary

Five Prime Therapeutics Inc  (FPRX)  $22.23    (%)

  • Symbol
    FPRX
    Price
    22.23$
    Beta
    1.95356
    Volume Avrg.
    948137
    Market Cap
    845578050
    Last Div
    0
    Range
    1.75-26.25
    Changes
    -0.85
    Changes Percentage
    Exchange
    Nasdaq Global Select
    Industry
    Biotechnology
    Ceo
    Mr. William Ringo
    Sector
    Healthcare

About company

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of innovative protein therapeutics. The company's product candidates comprise Bemarituzumab, an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, which is in Phase 3 clinical trials to treat patients with gastric or gastroesophageal junction and GEJ cancer; and FPA150, a CD8 T cell checkpoint inhibitor antibody that is in Phase 1a/1b clinical trial that targets B7-H4 in various cancers, as well as FPT155, a soluble CD80 fusion protein, which is in Phase 1a/1b clinical trial that enhances co-stimulation of T cells through CD28. Its product candidates also include Cabiralizumab, an antibody that inhibits colony stimulating factor-1 receptor that is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with Opdivo. The company's BMS-986258, an anti-T cell immunoglobulin and mucin domain-3 antibody, which is in Phase 1/2 clinical trial as a single agent and in combination with Opdivo in patients with advanced malignant tumors. It has license and collaboration agreements with Bristol-Myers Squibb Company, GlaxoSmithKline LLC, INBRX 110 LP, UCB Pharma S.A., and Zai Lab (Shanghai) Co., Ltd.; and license agreements with Galaxy Biotech, LLC, BioWa, Inc. and Lonza Sales AG. The company was founded in 2001 and is headquartered in South San Francisco, California.


Income Statement

Year Revenue Cost of revenues Gross profit Operating expensess Operating incomes Interest expense Income tax expenses Earnings before taxs Net income Earnings per share basics Earnings per share diluteds Dividend per shares Gross margins EBIT margins Profit margins EBITDA EBIT Earnings Before Tax Margins Net Profit Margins
2020 274515.00 169559.00 104956.00 38668.00 66288.00 0.00 968.00 67091.00 57411.00 3.31 3.28 0.803333414346 0.382332477278109 0.300289471658 0.209136112780722 77344.00 66288.00 0.244398302460703 0.209136112780722
2019 260174.00 161782.00 98392.00 34462.00 6393.00 3576.00 10481.00 65737.00 55256.00 2.97145 2.97145 3.03705403822 0.378178 0.245720171885 0.212381 8186.00 6393.00 0.252666 0.212381
2018 265595.00 163756.00 101839.00 30941.00 70898.00 324.00 11872.00 72903.00 59531.00 2.97649 2.97649 2.74234021698 0.383437 0.266940266195 0.224142 85546.00 70898.00 0.274489 0.224142
2017 229234.00 141048.00 88186.00 26842.00 61344.00 2323.00 15738.00 64089.00 48351.00 2.3175 2.3025 2.43140686849 0.384698604918991 0.267604282087 0.210924208450753 76569.00 61344.00 0.27957894553164 0.210924208450753
2016 215639.00 131376.00 84263.00 24239.00 60024.00 1456.00 15685.00 61372.00 45687.00 2.07658 2.07658 2.20897805039 0.39076 0.278354101067 0.211868 73333.00 60024.00 0.284605 0.211868
2015 233715.00 140089.00 93626.00 22396.00 7123.00 733.00 19121.00 72515.00 53394.00 2.30422 2.30422 1.99566067658 0.400599 0.304772907173 0.228458 84505.00 7123.00 0.310271 0.228458
2014 182795.00 112258.00 70537.00 18034.00 52503.00 384.00 13973.00 53483.00 3951.00 1.61318 1.61318 1.817183144 0.38588 0.287223392325 0.216144 61813.00 52503.00 0.292585 0.216144
2013 17091.00 106606.00 64304.00 15305.00 48999.00 136.00 13118.00 50155.00 37037.00 1.41969 1.41969 11.338876116 0.376245 0.286694751624 0.216705 57048.00 48999.00 0.293459 0.216705
2012 156508.00 87846.00 68662.00 13421.00 55241.00 1088.00 1403.00 55763.00 41733.00 1.57673 1.57673 2.63181556135 0.438712 0.35295959312 0.266651 60128.00 55241.00 0.356295 0.266651
2011 108249.00 64431.00 43818.00 10028.00 3379.00 519.00 8283.00 34205.00 25922.00 0.98833 0.98833 0.0 0.404789 0.312150689614 0.239466 36538.00 3379.00 0.315984 0.239466
2010 65225.00 39541.00 25684.00 7299.00 18385.00 311.00 4527.00 1854.00 14013.00 0.54121 0.54121 0.0 0.393775 0.281870448448 0.214841 19878.00 18385.00 0.284247 0.214841
2009 42905.00 25683.00 17222.00 5482.00 1174.00 407.00 3831.00 12066.00 8235.00 0.32426 0.32426 0.0 0.401398 0.2812 0.191936 13207.00 12066.00 0.281226 0.191936
Year202020192018201720162015201420132012201120102009
Revenue274515.00260174.00265595.00229234.00215639.00233715.00182795.0017091.00156508.00108249.0065225.0042905.00
Cost of revenues169559.00161782.00163756.00141048.00131376.00140089.00112258.00106606.0087846.0064431.0039541.0025683.00
Gross profit 104956.00 98392.00 101839.00 88186.00 84263.00 93626.00 70537.00 64304.00 68662.00 43818.00 25684.00 17222.00
Operating expensess38668.0034462.0030941.0026842.0024239.0022396.0018034.0015305.0013421.0010028.007299.005482.00
Operating incomes66288.006393.0070898.0061344.0060024.007123.0052503.0048999.0055241.003379.0018385.001174.00
Interest expense0.003576.00324.002323.001456.00733.00384.00136.001088.00519.00311.00407.00
Income tax expenses968.0010481.0011872.0015738.0015685.0019121.0013973.0013118.001403.008283.004527.003831.00
Earnings before taxs67091.0065737.0072903.0064089.0061372.0072515.0053483.0050155.0055763.0034205.001854.0012066.00
Net income57411.0055256.0059531.0048351.0045687.0053394.003951.0037037.0041733.0025922.0014013.008235.00
Earnings per share basics3.312.971452.976492.31752.076582.304221.613181.419691.576730.988330.541210.32426
Earnings per share diluteds3.282.971452.976492.30252.076582.304221.613181.419691.576730.988330.541210.32426
Dividend per shares0.83.042.742.432.2121.8211.342.63000
Gross margins0.380.380.380.380.390.40.390.380.440.40.390.4
EBIT margins0.30.250.270.270.280.30.290.290.350.310.280.28
Profit margins0.210.210.220.210.210.230.220.220.270.240.210.19
EBITDA77344.008186.0085546.0076569.0073333.0084505.0061813.0057048.0060128.0036538.0019878.0013207.00
EBIT66288.006393.0070898.0061344.0060024.007123.0052503.0048999.0055241.003379.0018385.0012066.00
Earnings Before Tax Margins0.240.250.270.280.280.310.290.290.360.320.280.28
Net Profit Margins0.210.210.220.210.210.230.220.220.270.240.210.19